Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc., a leading biotechnology company based in the United States, focuses on developing innovative therapies for neurological disorders. Founded in 1995, Acorda has made significant strides in the industry, particularly with its core products aimed at improving mobility and quality of life for patients with conditions such as multiple sclerosis and spinal cord injury. Headquartered in Ardsley, New York, Acorda operates primarily in the US, with a commitment to advancing scientific research and clinical development. The company’s flagship products, including Ampyra, are distinguished by their unique mechanisms of action that enhance walking ability in patients. Acorda's dedication to innovation and patient-centric solutions has solidified its position as a notable player in the biotechnology sector, contributing to advancements in neurological care.
DitchCarbon Score
How does Acorda Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Acorda Therapeutics, Inc.'s score of 20 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Acorda Therapeutics, Inc.'s reported carbon emissions
Acorda Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As the biopharmaceutical industry increasingly focuses on sustainability, Acorda's lack of disclosed climate strategies may reflect a broader trend within the sector, where many companies are still developing their environmental policies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Acorda Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
